TARGETED KIT MUTATION RESEARCH
Accutest LyoMorph-Q
KIT Mutation Detection Kit
Cost-effective and highly sensitive qPCR kit including lyophilized inhibitor-tolerant reagent mix with multiplex allele-specific primer-probe mix for detection of three KIT codon 816 variants in cfDNA, gDNA and FFPE-derived tissue DNA.
*Nominal capacity before controls, repeats or invalid reactions. One multiplex primer/probe reaction is required per sample.
1 multiplex qPCR reaction
multiplex reaction
for all three variants
reported study conditions
KIT codon 816 variants
One LyoMorph-Q platform. A growing oncology portfolio.
LyoMorph-Q uses a lyophilized inhibitor-tolerant reagent mix with standardized chemistry and cycling conditions across compatible targeted mutation panels, allowing multiple assays to run together on the same 96-well qPCR plate. The expanding portfolio supports focused solid- and blood-cancer research using cfDNA, FFPE-derived gDNA and gDNA.
Common workflow
Combine compatible mutation panels on one plate to improve throughput and reduce separate runs.
Growing assay menu
Build a scalable targeted-testing menu across established solid- and blood-cancer research panels.
Custom assay development
Discuss bespoke targets and panel combinations, including feasibility and low-minimum-order options.
Oncology technical support
Jant and shard-dx™ can support instrument compatibility, assay selection, evaluation planning and technical review.
Accutest LyoMorph-Q oncology assays are powered by SHARD DIAGNOSTICS™ (Nottingham, England). All products are for Research Use Only and are not for use in diagnostic procedures.
Ultrasensitive KIT research in one multiplex reaction
The kit combines mutation-specific amplification for three KIT codon 816 variants with an endogenous RNase P internal control and a dPCR-quantified positive control. No separate preamplification or post-PCR mutation-detection step is required.
The multiplex reaction uses the universal LyoMorph-Q mastermix and shared cycling profile, supporting integration alongside compatible mutation panels on the same 96-well plate.
Use familiar qPCR workflows
Simple to adopt by using your existing cycler and expertise.
Support broad input requirements
Supports inputs from 1 ng, with maximum inputs of 30 ng cfDNA, 25 ng FFPE-derived gDNA and 100 ng gDNA.
Reduce cold-chain burden
Lyophilized chemistry supports ambient shipping. Follow the current documentation for storage after receipt and reconstitution.
Simplify analysis
Fixed thresholding supports simplified analysis through enhanced specificity.
Built for focused KIT codon 816 research
One multiplex reaction detects KIT D816Y, D816H and D816V in FAM with an endogenous RNase P internal control in HEX.
Low-copy detection across three KIT codon 816 variants
All three KIT variants have a reported 95% limit of detection of three mutant copies at 0.01% VAF. Performance should be interpreted together with DNA input and absolute mutant-molecule availability.
low-copy detection
D816Y, D816H and D816V
Specificity in the reported study conditions
No false-positive mutation calls were reported at the tested wild-type inputs:
Results describe the reported study conditions and do not guarantee that false positives are impossible in every sample or laboratory.
| Protein change / control | Sequence change | Reaction | Fluorophore | Reported 95% LoD |
|---|---|---|---|---|
| D816Y | c.2446G>T | 1 | FAM | 3 copies • 0.01% VAF |
| D816H | c.2446G>C | 1 | FAM | 3 copies • 0.01% VAF |
| D816V | c.2447A>T | 1 | FAM | 3 copies • 0.01% VAF |
| RNase P internal control | Human DNA control | 1 | HEX | Not applicable |
From extracted DNA to an interpretable run
Extract and quantify
Prepare cfDNA, gDNA or FFPE-derived DNA and verify input concentration.
Reconstitute reagents
Rehydrate the lyophilized reagent mix with the specified buffer according to the current protocol.
Prepare the multiplex reaction
Combine the KIT/RNase P primer-probe mix with the sample and appropriate controls.
Run and interpret
Use the specified cycling and analysis settings. The universal 45-cycle program is approximately 75 minutes.
KIT mutation kit FAQs
What is the reported limit of detection?
The reported 95% LoD is three mutant copies at 0.01% VAF for each of the three KIT variants.
Can compatible mutation panels run on the same plate?
Compatible LyoMorph-Q mutation panels use a universal mastermix and shared cycling profile, allowing multiple panels to run on the same 96-well qPCR plate. Instrument optics, fluorescence channels and each assay’s requirements must still be locally verified.
Which sample types are supported?
The KIT assay supports cfDNA, gDNA and FFPE-derived tissue DNA. The minimum input is 1 ng; maximum inputs are 30 ng cfDNA, 25 ng FFPE-derived gDNA and 100 ng gDNA.
Is the assay quantitative?
The kit is designed primarily for sensitive mutation screening, not absolute mutant copy-number quantification. Ct values should not be interpreted directly as mutant molecule counts.
How long is the PCR program?
The universal LyoMorph-Q cycling profile uses a 45-cycle, one-phase program completed in approximately 75 minutes on a standard 96-well qPCR cycler.
How is the kit shipped and stored?
The lyophilized kit supports ambient shipping. Follow the current product documentation for component-specific storage, reconstitution and stability requirements after receipt.
Is this KIT workflow a fit for your laboratory?
Tell us your sample type, target requirements and qPCR instrument. Jant’s molecular team can help review compatibility, documentation and evaluation needs.


